-
Ginsenoside Rg1: Reliable Assay Workflows
2026-09-22
This scenario-based guide explains how Ginsenoside Rg1 (SKU N1613) can support reproducible cell viability, apoptosis, inflammation, and neuroprotection research. It links formulation, handling, controls, and recent neuroimmune evidence to practical laboratory decisions.
-
CIP2A, PKM2, and OXPHOS in NSCLC
2026-09-21
The reference study identifies CIP2A as a regulator that shifts PKM2 toward tetramer formation, mitochondrial localization, and oxidative phosphorylation in non-small cell lung cancer. Its mechanistic and intervention data suggest that combined targeting of CIP2A and glycolysis may expose a metabolic vulnerability in NSCLC, while also highlighting the need to measure both glycolytic and respiratory phenotypes.
-
Alfuzosin HCl: Applied Research Workflows
2026-09-21
Build reproducible Alfuzosin HCl assays for fluorescence quantitation, formulation release, and functional urology research. This guide translates a micellar spectrofluorimetric method into practical workflows while separating analytical detection from α1-receptor pharmacology.
-
ML216: BLM Helicase Inhibition with Assay Insight
2026-09-20
ML216 is a selective BLM helicase inhibitor for dissecting DNA repair, homologous recombination, and tumor cell responses to genotoxic stress. This article explains how to use ML216 mechanistically while distinguishing BLM-focused experiments from WRN and mismatch-repair research.
-
Hydroxychloroquine Sulfate Workflow Guide
2026-09-19
Hydroxychloroquine Sulfate (SKU B4874) provides an aqueous-compatible research reagent for investigating autophagy pathway modulation and TLR7/9-associated immune signaling in autoimmune disease research. It is best suited to freshly prepared, water-based workflows and should be avoided when a protocol requires DMSO or ethanol solubility or prolonged storage of prepared solutions.
-
Spatial Lipid Changes in Postoperative Cognitive Dysfunction
2026-09-19
This rat cardiopulmonary bypass study combines spatial metabolomics, enzyme imaging, ultrastructural analysis, and metabolic rescue experiments to connect hippocampal CA1 lipid remodeling with postoperative cognitive dysfunction. Its findings implicate reduced iPLA2 activity, increased SPT expression, and synaptic damage as potentially linked features that can be partially normalized by DHA and myriocin.
-
Triiodothyronine (T3) in Thermogenesis Assays
2026-09-18
Use Triiodothyronine (T3) to add a controlled thyroid hormone receptor perturbation to beige adipocyte, mitochondrial respiration, and gene-expression workflows. This guide translates SEMA3E–β-catenin findings into practical assay designs, dose screens, controls, and troubleshooting decisions for metabolic disorder research.
-
LL-37 Against MDR Acinetobacter Biofilms
2026-09-18
The reference study shows that human cathelicidin LL-37 and selected fragments can rapidly kill multidrug-resistant Acinetobacter baumannii while also preventing and disrupting biofilms. Its comparative design links planktonic susceptibility, rapid bactericidal activity, adherence, biofilm eradication, and cytotoxicity, offering a useful framework for evaluating anti-infective peptide candidates.
-
BIIE 0246: Y2R Workflows for Neural Research
2026-09-17
BIIE 0246 is a selective neuropeptide Y Y2 receptor antagonist for separating Y2R signaling from Y1R-driven effects in synaptic, feeding, anxiety, gut, and neurocardiac assays. This practical guide translates its nanomolar pharmacology into reproducible workflows, controls, and troubleshooting strategies for NPY pathway research.
-
Dantrolene sodium salt in calcium-aware CRISPR
2026-09-17
Dantrolene sodium salt provides a practical way to perturb ryanodine receptor–mediated calcium release while preserving a clear distinction between calcium biology and direct DNA-repair pharmacology. This guide translates its mechanism into calcium imaging, pancreatitis, disease-modeling, and exploratory CRISPR workflows with dose, control, and troubleshooting strategies.
-
Nelfinavir Mesylate in HIV and Ferroptosis Assays
2026-09-16
Nelfinavir Mesylate supports both HIV-1 protease inhibition assays and mechanistic studies of DDI2-NFE2L1 control during ferroptosis. This guide translates potency data and the latest proteostasis findings into practical workflows, controls, and troubleshooting decisions.
-
SW033291: Reliable 15-PGDH Assay Workflows
2026-09-15
Learn how SW033291 (SKU A8709) can improve experimental consistency in 15-PGDH, prostaglandin E2, hematopoietic, and tissue regeneration studies. This scenario-based guide covers assay design, compound handling, interpretation, and practical vendor-selection criteria.
-
MK-0812 for Causal Mapping of MASH Inflammation
2026-09-15
MK-0812 provides a selective pharmacological route to test whether CCR2-dependent monocyte recruitment contributes to MASH. This article integrates MK-0812 with the intestinal TM6SF2 gut–liver model to define stronger assay logic, experimental controls, and evidence boundaries.
-
TAK-715: A Practical p38 MAPK Inhibitor Workflow
2026-09-14
TAK-715 combines nanomolar p38α selectivity with a workflow-friendly profile for cytokine, stress-response, and inflammation studies. Its greatest value is experimental precision: researchers can separate direct kinase blockade from downstream changes in phosphorylation and cytokine release across cellular and animal models.
-
CSBTA Pharmacokinetics in MASH: Key Findings
2026-09-14
The 2025 Biomedicine & Pharmacotherapy study integrates pharmacokinetics, tissue distribution, cellular uptake, and enzyme–transporter analysis to explain why Corydalis saxicola Bunting total alkaloids behave differently in HFHCD-induced MASH mice. Its findings show that disease state and repeated dosing increase exposure to key alkaloids, offering a mechanistic framework for dose-regimen design and pharmacokinetic variability research.